Mammalian expression systems for hepatitis C virus envelope genes
US5610009A · kind A · utility
13Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 1994 |
| Grant date | Mar 11, 1997 |
| Priority date | — |
| Expiry date | Jan 28, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/82
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mammalian expression systems for the production of HCV E1-E2 fusion proteins. Such expression systems provide high yields of HCV proteins extracelluarly, and enable the development of diagnostic, vaccine and therapeutic reagents which contain glycosylated structural antigens and also allow for the isolation of the HCV etiological agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.